Prescribing Pattern of Ampicillin and Cloxacillin: Sensitivity and Responsiveness in Pneumonia

Antibiotic resistance

Authors

  • Haleema Shah Department of Pharmacy
  • Uzma Bibi Department of Pharmacy, Shaheed Benazir Bhutto University, Sheringal, Dir (Upper), Pakistan
  • Zul Kamal School of Pharmacy, Shanghai Jiao Tong University, Minhang 800, Shanghai 200240, China
  • Muhammad Esa Department of Pharmacy, Shaheed Benazir Bhutto University, Sheringal, Dir (Upper), Pakistan
  • Muhammad Naeem District Headquarter Hospital, Timergara, Dir (Lower), Khyber Pakhtunkhwa, Pakistan
  • Saleh Ahmad District Headquarter Hospital, Timergara, Dir (Lower), Khyber Pakhtunkhwa, Pakistan
  • Muhammad Shafique Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia

DOI:

https://doi.org/10.53560/PPASB(60-sp1)792

Keywords:

Ampicillin, Cloxacillin, Antibiotic responsiveness, Antimicrobial resistance (AMR), Hospital longevity

Abstract

Antimicrobial resistance (AMR) is now a global pandemic and a future threat to the existence of many clinical antibiotics. The excessive overuse in fisheries, poultries, and dairy farms and its irrational prescribing practices are the key factors that lead us to AMR explosions. The current main research objective is to evaluate the empirical practices of ampicillin along with cloxacillin, which are one of the running antibiotics in clinical practices, in most of the tertiary care hospitals in Khyber Pakhtunkhwa, Pakistan. In this study, the prescribing attitude, sensitivity and responsiveness of these two combinatory antibiotics (ampicillin-cloxacillin) in pediatric/adult pneumonia patients were evaluated in one of the public sector tertiary care hospitals in Mardan. Retrospective data was collected from pediatric ward A and medical A ward (adult), among which a total of n= 90 patient’s prescriptions were evaluated for prescribing practices, WHO core indicators, polypharmacy as well as responsiveness and sensitivity of ampicillin and cloxacillin from hospital longevity. The ampicillin responsiveness was sorted out among all those patients that stayed for a long time in the hospital, and during which the antibiotic therapies were switched from time to time. A total of n= 90 pneumonia patients (40 % & 60 % female) cases were evaluated for ampicillin/cloxacillin (combination) hospital stay longevity and responsiveness. 46 % of patients were under the age of 1–20 years, whereas 31 % were adults between the age of 61–80 years. WHO indicators revealed, that in the prescribed medications (n=918 drugs total, among n=90 patients) 22.33 % of antibiotics were prescribed, where 31.37 % consisted of injectables. Among the antibiotics classes, 17 % of pneumonia patients received penicillin, among which 26.25 % were ampicillin + cloxacillin in the prescribing practices. Ampicillin + cloxacillin responsiveness in pneumonia patients was recorded from the hospital stay and longevity (days) of the patients during their empirical therapy. 46.98 % of pneumonia patients recovered within three days, whereas 40.96 % of patients recovered within six days with ampicillin + cloxacillin (combination therapy). While 10.84 % were stabilized within nine days, though, some patients (1.20 %), recovered after 12 days with ampicillin/cloxacillin (combination therapy). Thus, it may be concluded from the current studies, that the decrease in responsiveness to ampicillin/cloxacillin (combination therapy) and the increase in the hospital longevity of patients, may be an indication of antimicrobial resistance (AMR) in pneumonia patients. Though the studies are limited to a very specific number of patients, as well as only to the hospital longevity (stay) parameters of the patients in a tertiary care hospital. These studies should be subjected further to more extensive vigilant research.

References

G. Mackenzie. The definition and classification of pneumonia. Pneumonia 8: 1-5 (2016).

Y. Rong, L. Tang, Y. Tian, J. Liu, and Z. Wu. Identification and classification of pneumonia disease using a deep learning-based intelligent computational framework. Neural Computing and Applications 1-14 (2021).

D.A. Rodrigo, J.P Yarzabal, J.P Cruz, J.P. Schmidt, J. Kleijnen, and J Johannes. Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review. Human vaccines & immunotherapeutics 12: 2422-2440 (2016).

I.F.N. Hung, T. Tantawichien, Y. H. Tsai, S. Patil, and R. Zotomayor. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. International Journal of Infectious Diseases 17: e364-e373 (2013).

M.I. Hutchings, A.W. Truman, and B. Wilkinson. Antibiotics: past, present and future. Current Opinion in Microbiology 51: 72-80 (2019).

V. Clifford, M. Tebruegge, M. Vandeleur, and N. Curtis. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin? Archives of Disease in Childhood 95: 73-77 (2010).

C. Cillóniz, C. Dominedò, and A. Torres. Multidrug resistant gram-negative bacteria in community-acquired pneumonia. Annual Update in Intensive Care and Emergency Medicine 2019: 459-475 (2019).

K. Hayat, Khezar, M. Rosenthal, A. H. Gillani, J. Chang, j. Wenjing , C. Yang, M. Jiang, M. Zhao, and Y. Fang. Perspective of key healthcare professionals on antimicrobial resistance and stewardship programs: a multicenter cross-sectional study from Pakistan. Frontiers in Pharmacology 10: 1520 (2020).

W. Wang, Y. Chang, S. Yu, X. Zhou, L. Wang, X. He, and H. Zhou. Antibiotic prescribing patterns for children’s outpatient department of primary care institutions in Southwest China. BMC Primary Care 23: 269 (2022).

T.V Shanbhag, S. Shenoy, and V. Nayak, Pharmacology for Dentistry, E-book. Published by Elsevier Health Sciences (2021).

G. Birgand, E. Castro-Sánchez, S. Hansen, P. Gastmeier, J.C Lucet, E. Ferlie, and R. Ahmad. Comparison of governance approaches for the control of antimicrobial resistance: analysis of three European countries. Antimicrobial Resistance & Infection Control 7:1-12 (2018).

R.V Katwyk, Susan, J.M Grimshaw, M. Nkangu, R.Nagi, M. Mendelson, M. Taljaard, and S.J. Hoffman. Government policy interventions to reduce human antimicrobial use: a systematic review and evidence map. PLoS Medicine 16: e1002819 (2019).

R.R. Uchil, G.S. Kohli, V.M. KateKhaye, and O.C. Swami. Strategies to combat antimicrobial resistance. Journal of Clinical and Diagnostic Research 8: ME01 (2014).

S. Zikria, M.A. Hassali, F.K. Hashmi, B. Godman, and F. Saleem. Antimicrobial dispensing practices and determinants of antimicrobial resistance: a qualitative study among community pharmacists in Pakistan. Family Medicine and Community Health 7: (2019).

M.S. Khan, A.D. Bagale, A. Mateus, Z. Sultana, R. Hasan, and J. Hanefeld. What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan. Health Policy and Planning 35: 973-982 (2020).

R. Jabeen, U. Rabbani, and N. Abbas. Situation analysis of antimicrobial resistance control, policy and regulation-a reflection of Pakistan. Pakistan Journal of Pharmaceutical Sciences 34: (2021).

C. Esmita, M. McKee, R. Ahmad, M. Balasegaram, C. Bonaconsa, G. B. Merrett, and R. Busse et al. Optimising antimicrobial use in humans review of current evidence and an interdisciplinary consensus on key priorities for research. The Lancet Regional Health-Europe 7: 100161 (2021).

J. Dušan, J. Littmann, A. Zorzet, and O. Cars. Antimicrobial resistance—a threat to the world’s sustainable development. Upsala Journal of Medical Sciences 121: 159-164 (2016).

C.A Michael, D.D. Howes, and M. Labbate, The antimicrobial resistance crisis: causes, consequences, and management. Frontiers in Public Health 2: 145 (2014).

R.D Smith, M.R. Keogh-Brown, and T. Barnett. Estimating the economic impact of pandemic influenza: an application of the computable general equilibrium model to the UK. Social Science and Medicine 73: 235-244 (2011).

L.Y. Tsung, Y.Y. Jeng, T.L. Chen, and C.P. Fung. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infectious Diseases 10: 1-7 (2010).

R. Asghar, S. Banajeh, J. Egas, P. Hibberd, I. Iqbal, M.K Bwalya, Z. Kundi, P. Law, W. MacLeod, I.M Radovan, and G. Mino. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). British Medical Journal 336: 80-84 (2008). .

W. Fonseca, K. Hoppu, L.C Rey, J. Amaral, and S. Qazi. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia. Antimicrobial Agents and Chemotherapy 47: 997-1001 (2003).

A.H Mariam, Y. Raghavendra, and E.M Bobasa. Evaluating rational drug use with the help of World Health Organization’s core indicators in Bule Hora Hospital, Southern Ethiopia. Encounters 7: 11 (2015).

D.B. Mamo, and B.K. Alemu. Rational drug-use evaluation based on World Health Organization core drug-use indicators in a tertiary referral hospital, Northeast Ethiopia: a cross-sectional Study. Drug, Healthcare and Patient Safety 12: 15 (2020).

M. Atif, M.R. Sarwar, M. Azeem, D. Umer, A. Rauf, A. Rasool, M. Ahsan, and S. Scahill. Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan. Journal of Pharmaceutical Policy and Practice 9: 1-8 (2016).

B.D. Mekonnen, M.Z. Ayalew, and A.A. Tegegn. Rational drug use evaluation based on world Health organization core drug use indicators in Ethiopia: a systematic review. Drug, Healthcare and Patient Safety 13: 159 (2021).

J.T.M. Shrestha, S. Tiwari, D.K Kushwaha, P. Bhattarai, and R. Shrestha. Drug Prescription in the Department of Medicine of a Tertiary Care Hospital according to the World Health Organization/International Network for Rational Use of Drugs Core Indicators: A Descriptive Crosssectional Survey. Journal of the Nepal Medical Association 59: 745 (2021).

C. Yue, S. Chusri, R. Sangthong, E. McNeil, J. Hu, W. Du, D. Li et al. Clinical pattern of antibiotic overuse and misuse in primary healthcare hospitals in the southwest of China. PLoS One 14: e0214779 (2019).

Downloads

Published

2023-01-17

How to Cite

Haleema Shah, Uzma Bibi, Zul Kamal, Muhammad Esa, Muhammad Naeem, Saleh Ahmad, & Muhammad Shafique. (2023). Prescribing Pattern of Ampicillin and Cloxacillin: Sensitivity and Responsiveness in Pneumonia: Antibiotic resistance. Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, 60(S), 65–75. https://doi.org/10.53560/PPASB(60-sp1)792

Issue

Vol. 60 No. S (2023): Special Issue: ANSO-PAS-MAAP Conference on Epidemic and Pandemic Preparedness

Section

Research Articles

License

Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.